206 related articles for article (PubMed ID: 34117242)
21. Genomic evolution and chemoresistance in germ-cell tumours.
Taylor-Weiner A; Zack T; O'Donnell E; Guerriero JL; Bernard B; Reddy A; Han GC; AlDubayan S; Amin-Mansour A; Schumacher SE; Litchfield K; Turnbull C; Gabriel S; Beroukhim R; Getz G; Carter SL; Hirsch MS; Letai A; Sweeney C; Van Allen EM
Nature; 2016 Nov; 540(7631):114-118. PubMed ID: 27905446
[TBL] [Abstract][Full Text] [Related]
22. Pediatric malignant germ cell tumors show characteristic transcriptome profiles.
Palmer RD; Barbosa-Morais NL; Gooding EL; Muralidhar B; Thornton CM; Pett MR; Roberts I; Schneider DT; Thorne N; Tavaré S; Nicholson JC; Coleman N;
Cancer Res; 2008 Jun; 68(11):4239-47. PubMed ID: 18519683
[TBL] [Abstract][Full Text] [Related]
23. Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability
Acosta AM; Sholl LM; Cin PD; Howitt BE; Otis CN; Nucci MR
Histopathology; 2020 Nov; 77(5):788-797. PubMed ID: 32558949
[TBL] [Abstract][Full Text] [Related]
24. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
[TBL] [Abstract][Full Text] [Related]
25. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
26. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract][Full Text] [Related]
27. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of an ovarian yolk sac tumor cell line reveals possible involvement of Nkx2.5 in tumor development.
Shibata K; Kajiyama H; Yamamoto E; Terauchi M; Ino K; Nawa A; Kikkawa F
Oncology; 2008; 74(1-2):104-11. PubMed ID: 18547965
[TBL] [Abstract][Full Text] [Related]
29. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors.
Chahoud J; Zhang M; Pisters LL; Lin SC; Lin SH; Tu SM
Clin Genitourin Cancer; 2018 Oct; 16(5):325-327. PubMed ID: 29807831
[No Abstract] [Full Text] [Related]
30. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
Kim SI; Lee JW; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
Gynecol Oncol; 2018 Feb; 148(2):375-382. PubMed ID: 29233531
[TBL] [Abstract][Full Text] [Related]
31. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.
Siltanen S; Anttonen M; Heikkilä P; Narita N; Laitinen M; Ritvos O; Wilson DB; Heikinheimo M
Am J Pathol; 1999 Dec; 155(6):1823-9. PubMed ID: 10595911
[TBL] [Abstract][Full Text] [Related]
32. Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.
Wang Y; Yang J; Yu M; Cao D; Zhang Y; Zong X; Shen K
Medicine (Baltimore); 2018 Aug; 97(33):e11838. PubMed ID: 30113473
[TBL] [Abstract][Full Text] [Related]
33. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.
Kraggerud SM; Hoei-Hansen CE; Alagaratnam S; Skotheim RI; Abeler VM; Rajpert-De Meyts E; Lothe RA
Endocr Rev; 2013 Jun; 34(3):339-76. PubMed ID: 23575763
[TBL] [Abstract][Full Text] [Related]
34. Gonadoblastoma-Associated Mixed Gonadal Germ Cell Tumor with Dysgerminoma and Hepatoid Yolk Sac Tumor Components in 46XY Gonadal Dysgenesis.
Losada DM; Benetti-Pinto CL; Andrade LALA
J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):558-560. PubMed ID: 31175959
[TBL] [Abstract][Full Text] [Related]
35. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.
Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants.
Kato N; Tamura G; Fukase M; Shibuya H; Motoyama T
Am J Pathol; 2003 Aug; 163(2):387-91. PubMed ID: 12875960
[TBL] [Abstract][Full Text] [Related]
37. Identification of a new missense mutation (Gly95Glu) in a highly conserved codon within the high-mobility group box of the sex-determining region Y gene: report on a 46,XY female with gonadal dysgenesis and yolk-sac tumor.
Schäffler A; Barth N; Winkler K; Zietz B; Rümmele P; Knüchel R; Schölmerich J; Palitzsch KD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2287-92. PubMed ID: 10852465
[TBL] [Abstract][Full Text] [Related]
38. An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1.
McCluggage WG; Fu L; Mohler K; de Kock L; Sabbaghian N; Mindlin A; Stewart CJR; Gilks CB; Foulkes WD
Int J Gynecol Pathol; 2022 Jul; 41(4):349-355. PubMed ID: 34380971
[TBL] [Abstract][Full Text] [Related]
39. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A
Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620
[No Abstract] [Full Text] [Related]
40. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
Magers MJ; Kao CS; Cole CD; Rice KR; Foster RS; Einhorn LH; Ulbright TM
Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]